Aptus Pharma Shareholders Approve Preferential Issue and Key AGM Resolutions
Aptus Pharma Ltd 路 Annual General Meeting 路 15 Sept 2026, 1:55 am
Aptus Pharma Shareholders Approve Preferential Issue and Key AGM Resolutions Aptus Pharma Limited announced the voting results of its 16th AGM held on 14th Sep'26. Shareholders unanimously approved all three proposed resolutions with 100% votes in favor across 13.94m votes polled. Key approvals include the adoption of FY26 audited financial statements, the re-appointment of Director Chetan Shantilal Lalseta retiring by rotation, and a special resolution approving the preferential allotment of equity shares. Remote e-voting concluded on 13th Sep'26, scrutinized by Practising Company Secretary Nalin Ganatra.
Original exchange filing (PDF)
More announcements from Aptus Pharma Ltd
- Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations, 2015 路 12 Nov 2026
- Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting for .... 路 06 Nov 2026
- Receipt of In-Principle Approval for Preferential Issue 路 31 Oct 2026
- Transcript for Earning Call for the Quarter and Half Year ended on September 30, 2026 路 30 Oct 2026
- Audio recording of the Earnings Call dated October 26, 2026 路 27 Oct 2026
- Intimation of Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 23 Oct 2026
- Intimation of Earnings Call for the quarter and half year ended September 30, 2026 路 26 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... 路 21 Oct 2026
